These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 28573628

  • 1. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A, Griffin BD, Qiu X, Kobinger G.
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Ebola Virus Countermeasures in Guinea Pigs.
    Marzi A.
    Methods Mol Biol; 2017; 1628():283-291. PubMed ID: 28573629
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models.
    Mire CE, Geisbert TW.
    Methods Mol Biol; 2017; 1628():293-307. PubMed ID: 28573630
    [Abstract] [Full Text] [Related]

  • 4. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A, Feldmann F, Geisbert JB, Mire CE, Hamm S, Nowak B, Egan MA, Geisbert TW, Eldridge JH, Feldmann H, Clarke DK.
    J Infect Dis; 2015 Oct 01; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
    Vu H, Shulenin S, Grolla A, Audet J, He S, Kobinger G, Unfer RC, Warfield KL, Aman MJ, Holtsberg FW.
    Antiviral Res; 2016 Feb 01; 126():55-61. PubMed ID: 26681387
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T, Draper K, Brasel T, Freiberg A, Squiquera L, Sidransky D, Sulley J, Taxman DJ.
    Antiviral Res; 2016 Aug 01; 132():210-8. PubMed ID: 27350309
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics.
    Lee HN, Xu B, Lewkowicz AP, Engel K, Kelley-Baker L, McWilliams IL, Ireland DDC, Kielczewski JL, Li J, Fariss RN, Campos MM, Baum A, Kyratsous C, Pascal K, Chan CC, Caspi RR, Manangeeswaran M, Verthelyi D.
    EBioMedicine; 2024 Jun 01; 104():105170. PubMed ID: 38823088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE, Matassov D, Geisbert JB, Latham TE, Agans KN, Xu R, Ota-Setlik A, Egan MA, Fenton KA, Clarke DK, Eldridge JH, Geisbert TW.
    Nature; 2015 Apr 30; 520(7549):688-691. PubMed ID: 25853476
    [Abstract] [Full Text] [Related]

  • 20. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
    Aviles J, Bello A, Wong G, Fausther-Bovendo H, Qiu X, Kobinger G.
    J Infect Dis; 2015 Oct 01; 212 Suppl 2():S389-97. PubMed ID: 26038398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.